# Efficacy & Safety of Prophylaxis With Bemiparin in Cancer Patients With a Central Venous Catheter (BECAT)

> **NCT00311896** · PHASE3 · TERMINATED · sponsor: **Clinica Universidad de Navarra, Universidad de Navarra** · enrollment: 402 (actual)

## Conditions studied

- Cancer
- Thrombosis

## Interventions

- **DRUG:** Bemiparin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00311896
- **Lead sponsor:** Clinica Universidad de Navarra, Universidad de Navarra
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-07
- **Primary completion:** 2009-02
- **Final completion:** 2010-12
- **Target enrollment:** 402 (ACTUAL)
- **Why stopped:** Sponsor stopped due to difficulties to recruit 402 patients required by protocol
- **Last updated:** 2012-06-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00311896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00311896, "Efficacy & Safety of Prophylaxis With Bemiparin in Cancer Patients With a Central Venous Catheter (BECAT)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00311896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*